Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy (Q38895066)

7 September 2017

title

Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy (English)

1 reference

7 September 2017

Xue Yang

1

1 reference

7 September 2017

Weihua Li

2

1 reference

7 September 2017

Pratheeba Palasuberniam

3

1 reference

7 September 2017

Kenneth A Myers

4

1 reference

7 September 2017

Chenguang Wang

5

1 reference

7 September 2017

Bin Chen

6

1 reference

7 September 2017

publication date

8 April 2015

1 reference

Photochemistry and Photobiology

7 September 2017

published in

1 reference

7 September 2017

volume

91

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

923-930

1 reference

Aminolevulinic acid (ALA): photodynamic detection and potential therapeutic applications

7 September 2017

cites work

1 reference

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.

21 January 2018

1 reference

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

21 January 2018

1 reference

A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia

21 January 2018

1 reference

Fluorescence Diagnosis of Metastatic Lymph Nodes Using 5-Aminolevulinic Acid (5-ALA) in a Mouse Model of Colon Cancer

21 January 2018

1 reference

21 January 2018

1 reference

The biochemistry of heme biosynthesis

21 January 2018

1 reference

Combination of phosphatidylinositol 3-kinases pathway inhibitor and photodynamic therapy in endothelial and tumor cells

21 January 2018

1 reference

Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size

21 January 2018

1 reference

Silencing of ALA dehydratase affects ALA-photodynamic therapy efficacy in K562 erythroleukemic cells

21 January 2018

1 reference

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer

21 January 2018

1 reference

siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines

21 January 2018

1 reference

Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy

21 January 2018

1 reference

Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes

21 January 2018

1 reference

Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation

21 January 2018

1 reference

Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer

21 January 2018

1 reference

Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid

21 January 2018

1 reference

Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma

21 January 2018

1 reference

Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PHP.12454

1 reference

7 September 2017

1 reference